Livent, Amgen And Some Other Big Stocks Moving Lower On Monday - Amgen (NASDAQ:AMGN)

U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session.

DICE Therapeutics, Inc. (NASDAQ:DICE) fell 19.6% to $18.20. Stifel, last week, initiated coverage on the stock with a Buy rating and a $37 price target.
Entrada Therapeutics, Inc. (NASDAQ:TRDA) dropped 11.4% to $13.21. Entrada Therapeutics, last month, posted a Q2 loss of $0.74 per share.
ShiftPixy, Inc. (NASDAQ:PIXY) fell 9.8% to $31.06 after gaining 11% on Friday.
Azure Power Global Limited (NYSE:AZRE) dropped 9.3% to $5.32.
Immatics N.V. (NASDAQ:IMTX) fell 9% to $11.69.
Microvast Holdings, Inc. (NASDAQ:MVST) declined 8.3% to $2.3197.
Construction Partners, Inc. (NASDAQ:ROAD) fell 7.8% to $28.00.
Forge Global Holdings, Inc. (NYSE:FRGE) dropped 7.8% to $4.04.
Burning Rock Biotech Limited (NASDAQ:BNR) declined 7.2% to $3.33.
Humacyte, Inc. (NASDAQ:HUMA) fell 7.1% to $4.19. Humacyte recently filed for mixed-securities shelf offering of up to $300 million.
Couchbase, Inc. (NASDAQ:BASE) dipped 7.1% to $14.49. The company, last week, posted upbeat quarterly results.
Livent Corporation (NYSE:LTHM) fell 5.8% to $32.46 after Verticle Research downgraded the stock from Buy to Hold and announced a $35 price target.
Amgen Inc. (NASDAQ:AMGN) dropped 3.7% to $238.44 following FDA approval of Bristol Myers Squibb's plaque psoriasis drug Sotyktu, which showed superior efficacy to Amgen's Otezla.